Gastric pentadecapeptide BPC-157, a stable peptide in clinical phase II, markedly counteracts esophagitis in two rat models. (CROSBI ID 726731)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
2. Sikiric, P. ; Seiwerth, S. ; Kopljar, M. ; Petrovic, I. ; Drvis, P. ; Dobric, I. ; Kokic, N. ; Jukić, Ivana ; Bedekovic, V. ; Kalogjera, L. ; Batelja, L. ; Blagaic, A. Boban ; Anic, T. ; Tomasovic, S.
engleski
Gastric pentadecapeptide BPC-157, a stable peptide in clinical phase II, markedly counteracts esophagitis in two rat models.
Gastric pentadecapeptide BPC-157, a stable peptide in clinical phase II, markedly counteracts esophagitis in two rat models.
rat, BPC 157
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
Digestive Diseases and Sciences
2003.
objavljeno
Podaci o matičnoj publikaciji
0163-2116
1573-2568
Podaci o skupu
11th International conference on ulcer research.
poster
01.01.2003-01.01.2003
Dubrovnik, Croatia
